PatentBrief · Patent BriefUS 4081538

Aldosterone antagonists

A method for increasing the excretion of sodium by inhibiting the effect of mineralocorticoids, involving the administration to a patient of a therapeutically effective amount of an 11β,18-oxidopregnane as an aldosterone

Patent Number

US 4081538

Status

Active

Filing Date

December 2, 1976

Grant Date

March 28, 1978

Expiration

~December 1996 (estimated)

Claims

5

Assignee

Individual

Inventors

Stanley Ulick

Citations

5 forward · 2 backward

What it covers

A method for increasing the excretion of sodium by inhibiting the effect of mineralocorticoids, involving the administration to a patient of a therapeutically effective amount of an 11β,18-oxidopregnane as an aldosterone antagonist.